{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:53:45Z","timestamp":1791201225300,"version":"4.2.0"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2014,9,29]],"date-time":"2014-09-29T00:00:00Z","timestamp":1411948800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0108489","type":"journal-article","created":{"date-parts":[[2014,9,29]],"date-time":"2014-09-29T19:15:18Z","timestamp":1412018118000},"page":"e108489","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":87,"title":["Risk of Narcolepsy Associated with Inactivated Adjuvanted (AS03) A\/H1N1 (2009) Pandemic Influenza Vaccine in Quebec"],"prefix":"10.1371","volume":"9","author":[{"given":"Jacques","family":"Montplaisir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Petit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Jos\u00e9e","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manale","family":"Ouakki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve","family":"Deceuninck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Desautels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Mignot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"De Wals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,9,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0140-6736(07)60237-2","article-title":"Narcolepsy with cataplexy","volume":"369(9560)","author":"Y Dauvilliers","year":"2007","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"12305","DOI":"10.1523\/JNEUROSCI.2630-12.2012","article-title":"Narcolepsy: neural mechanisms of sleepiness and cataplexy","volume":"32(36)","author":"CR Burgess","year":"2012","journal-title":"J Neurosci"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/sleep\/30.1.13","article-title":"The epidemiology of narcolepsy","volume":"30(1)","author":"WT Longstreth Jr","year":"2007","journal-title":"Sleep"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0960-5428(94)00043-N","article-title":"Narcolepsy and immunity","volume":"5(1)","author":"E Mignot","year":"1995","journal-title":"Adv Neuroimmunol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jaut.2013.02.003","article-title":"Genetic association, seasonal infections and autoimmune basis of narcolepsy","volume":"43","author":"AK Singh","year":"2013","journal-title":"J Autoimmun"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1093\/sleep\/17.suppl_8.S50","article-title":"Life events in the year preceding the onset of narcolepsy","volume":"17","author":"C Orellana","year":"1994","journal-title":"Sleep"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1093\/sleep\/17.suppl_8.S25","article-title":"Posttraumatic narcolepsy in mild to moderate closed head injury","volume":"17","author":"DA Lankford","year":"1994","journal-title":"Sleep"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000111581","article-title":"A case-control study of the environmental risk factors for narcolepsy","volume":"29(3\u20134)","author":"D Picchioni","year":"2007","journal-title":"Neuroepidemiology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"e33536","DOI":"10.1371\/journal.pone.0033536","article-title":"AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland","volume":"7(3)","author":"H Nohynek","year":"2012","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e33723","DOI":"10.1371\/journal.pone.0033723","article-title":"Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland","volume":"7(3)","author":"M Partinen","year":"2012","journal-title":"PLoS One"},{"key":"ref11","unstructured":"National Narcolepsy Study Steering Committee (2012) Investigation of an increase in the incidence of narcolepsy in children and adolescents in 2009 and 2010. Dublin, Ireland: Department of Health and Children. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.dohc.ie\/publications\/pdf\/Final_Report_of_National_Narcolepsy_Study_Steering_Committee.pdf?direct=1\" xlink:type=\"simple\">http:\/\/www.dohc.ie\/publications\/pdf\/Final_Report_of_National_Narcolepsy_Study_Steering_Committee.pdf?direct=1<\/ext-link>. Accessed 2014 Sept 1."},{"key":"ref12","unstructured":"ECDC Technical Report (2012) Narcolepsy in association with pandemic influenza vaccination. Stockholm: European Centre for Disease Prevention and Control. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/Vaesco%20in%20brief%20final.pdf\" xlink:type=\"simple\">http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/Vaesco%20in%20brief%20final.pdf<\/ext-link>. Accessed 2014 Sept 1."},{"key":"ref13","doi-asserted-by":"crossref","first-page":"f794","DOI":"10.1136\/bmj.f794","article-title":"Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A\/H1N1 2009 influenza vaccine: retrospective analysis","volume":"346","author":"E Miller","year":"2013","journal-title":"BMJ"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/sleep\/33.11.1428","article-title":"Post-H1N1 narcolepsy-cataplexy","volume":"33(11)","author":"Y Dauvilliers","year":"2010","journal-title":"Sleep"},{"key":"ref15","unstructured":"Minist\u00e8re de la Sant\u00e9 et des Services sociaux du Qu\u00e9bec (MSSS) (2011) Bilan de la direction g\u00e9n\u00e9rale de la sant\u00e9 publique de la vaccination contre la grippe pand\u00e9mique A(H1N1) 2009. Du 22 octobre au 18 d\u00e9cembre 2009. Qu\u00e9bec: Direction de la protection de la sant\u00e9 publique, Minist\u00e8re de la Sant\u00e9 et des Services sociaux du Qu\u00e9bec, 2011. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/publications.msss.gouv.qc.ca\/acrobat\/f\/documentation\/2011\/11-220-02.pdf\" xlink:type=\"simple\">http:\/\/publications.msss.gouv.qc.ca\/acrobat\/f\/documentation\/2011\/11-220-02.pdf<\/ext-link>. Accessed 2014 Sept 1."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.vaccine.2012.12.014","article-title":"Narcolepsy as an adverse event following immunization: Case definition and guidelines for data collection, analysis and presentation","volume":"31(6)","author":"F Poli","year":"2013","journal-title":"Vaccine"},{"key":"ref17","first-page":"175","article-title":"Risk of Guillain-Barr\u00e9 Syndrome following H1N1 influenza vaccination in Quebec","volume":"308(2)","author":"P De Wals","year":"2012","journal-title":"JAMA"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/sim.2302","article-title":"Tutorial in biostatistics: The self-controlled case series method","volume":"25(10)","author":"HJ Whitaker","year":"2006","journal-title":"Stat Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/oxfordjournals.epirev.a036147","article-title":"Evaluating vaccination effectiveness and vaccine efficacy by means of case-control studies","volume":"16(1)","author":"GW Comstock","year":"1994","journal-title":"Epidemiol Rev"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/sleep\/25.2.197","article-title":"The epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study","volume":"25(2)","author":"MH Silber","year":"2002","journal-title":"Sleep"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.vaccine.2012.12.015","article-title":"The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1) pdm09 pandemic and vaccination campaigns","volume":"31(8)","author":"L Wijnans","year":"2013","journal-title":"Vaccine"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.sleep.2003.06.002","article-title":"Factors associated with a delay in the diagnosis of narcolepsy","volume":"5(1)","author":"E Morrish","year":"2004","journal-title":"Sleep Medicine"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/sleep\/15.5.415","article-title":"DQB1-0602 (DQw1) is not present in most nonDR2 Caucasian narcoleptics","volume":"15(5)","author":"E Mignot","year":"1992","journal-title":"Sleep"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/sleep\/9.1.153","article-title":"HLA antigens in narcolepsy and idiopathic central nervous system hypersomnolence","volume":"9(1 Pt 2)","author":"G Poirier","year":"1986","journal-title":"Sleep"},{"key":"ref25","first-page":"1012","article-title":"HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients","volume":"20(11)","author":"E Mignot","year":"1997","journal-title":"Sleep"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1399-0039.1997.tb02761.x","article-title":"Extensive HLA class II studies in 58 non-DRB1*15 (DR2) narcoleptic patients with cataplexy","volume":"49(4)","author":"E Mignot","year":"1997","journal-title":"Tissue Antigens"},{"key":"ref27","unstructured":"Institut national de sant\u00e9 publique du Qu\u00e9bec (INSPQ) (2010) Bilan \u00e9pid\u00e9miologique de la pand\u00e9mie d\u2019influenza A(H1N1). Province de Qu\u00e9bec\u20132009. Qu\u00e9bec: Direction des risques biologiques et de la sant\u00e9 au travail, Institut national de sant\u00e9 publique du Qu\u00e9bec, 2010. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.inspq.qc.ca\/pdf\/publications\/1212_BilanAH1N12009.pdf\" xlink:type=\"simple\">http:\/\/www.inspq.qc.ca\/pdf\/publications\/1212_BilanAH1N12009.pdf<\/ext-link>. Accessed 2014 Sept 1."},{"key":"ref28","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/ana.23799","article-title":"Decreased incidence of childhood narcolepsy 2 years after the 2009 H1N1 winter flu pandemic","volume":"73(4)","author":"F Han","year":"2013","journal-title":"Ann Neurol"},{"key":"ref29","first-page":"410","article-title":"Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China","volume":"70(3)","author":"F Han","journal-title":"Ann Neurol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"7439","DOI":"10.1016\/j.vaccine.2012.10.030","article-title":"No association between influenza A (H1N1) pdm09 vaccination and narcolepsy in South Korea: An ecological study","volume":"30(52)","author":"YJ Choe","year":"2012","journal-title":"Vaccine"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"c7297","DOI":"10.1136\/bmj.c7297","article-title":"Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009","volume":"342","author":"DM Skowronski","year":"2011","journal-title":"BMJ"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1750-2659.2010.00146.x","article-title":"Protective effect of single-dose adjuvanted pandemic influenza vaccine in children","volume":"4(4)","author":"PG Van Buynder","year":"2010","journal-title":"Influenza Other Respir Viruses"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e68402","DOI":"10.1371\/journal.pone.0068402","article-title":"No serological evidence of influenza A H1N1pdm09 virus infection as a contributing factor in childhood narcolepsy after Pandemrix vaccination campaign in Finland","volume":"8(8)","author":"K Mel\u00e8n","year":"2013","journal-title":"PLoS ONE"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.sleep.2013.03.020","article-title":"Incidence of narcolepsy in Norwegian children and adolescents after vaccination against H1N1 influenza A","volume":"14","author":"MS Heier","year":"2013","journal-title":"Sleep Medicine"},{"key":"ref35","unstructured":"Medical Product Agency (2011) Occurrence of narcolepsy with cataplexy among children and adolescents in relation to the H1N1 pandemic and Pandemrix vaccinations - Results of a case inventory study by the MPA in Sweden during 2009\u20132010. Stockholm, Sweden: L\u00e4kemedelsverket. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.lakemedelsverket.se\/upload\/nyheter\/2011\/Fallinventeringsrapport_pandermrix_110630.pdf\" xlink:type=\"simple\">http:\/\/www.lakemedelsverket.se\/upload\/nyheter\/2011\/Fallinventeringsrapport_pandermrix_110630.pdf<\/ext-link>. Accessed 2014 Sept 1."},{"key":"ref36","unstructured":"European Medicine Agency (2013) Pandemrix: EPAR-Product Information Annex I: Summary of product characteristics. London (UK): European Medicine Agency. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000832\/WC500038121.pdf\" xlink:type=\"simple\">http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000832\/WC500038121.pdf<\/ext-link>. Accessed 2014 Sept 1."},{"key":"ref37","unstructured":"GlaxoSmithKline Inc (2009) Product Information Leaflet Arepanrix H1N1 AS03-Adjuvanted H1N1 Pandemic Influenza Vaccine - Version 4 approved 20 April 2010. Ottawa: Health Canada, 2010. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.hc-sc.gc.ca\/dhp-mps\/alt_formats\/pdf\/prodpharma\/legislation\/interimorders-arretesurgence\/prodinfo-vaccin-eng.pdf\" xlink:type=\"simple\">http:\/\/www.hc-sc.gc.ca\/dhp-mps\/alt_formats\/pdf\/prodpharma\/legislation\/interimorders-arretesurgence\/prodinfo-vaccin-eng.pdf<\/ext-link>. Accessed 2014 Sept 1."},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2014.01.033","article-title":"Narcolepsy 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: What is known and unknown about the neurological disorder, the role of autoimmunity, and vaccine adjuvants","volume":"50","author":"SS Ahmed","year":"2014","journal-title":"J Autoimmunity"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0108489","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T14:12:02Z","timestamp":1540217522000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0108489"}},"subtitle":[],"editor":[{"given":"Suryaprakash","family":"Sambhara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,9,29]]},"references-count":38,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2014,9,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0108489","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,29]]}}}